Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Management of Ureteral Stents in PCN-Related Infections

Primary Management Strategy

  • The American College of Radiology recommends starting empiric antibiotics immediately with ceftriaxone or ampicillin/sulbactam to cover expected uropathogens, which reduces serious sepsis-related complications from 50% to 9% in high-risk patients 1, 2
  • Obtaining blood and urine cultures before initiating antibiotics is crucial, then adjusting therapy based on sensitivities, as recommended by the American College of Radiology 2

Device-Specific Considerations

  • Internal double-J ureteral stents are particularly prone to infection, with reported rates of 11%, according to the American Cancer Society 1
  • In patients with urinary diversions, double-J stents occlude quickly from mucous plugging and should be avoided in favor of percutaneous nephroureteral catheters, as suggested by the American College of Radiology 3, 4

Prevention Strategy

  • The American College of Radiology recommends periodic reassessment of device necessity with removal when no longer required, as infection risk correlates directly with duration of placement 1, 2
  • Using preprocedural antimicrobial prophylaxis with ceftriaxone or ampicillin/sulbactam is recommended for planned exchanges, according to the American Cancer Society 1, 2